Upgrade to SI Premium - Free Trial

Optimizerx Corporation (OPRX)

9.13 +0.05 (0.55%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Form SCHEDULE 13G/A OptimizeRx Corp Filed by: ROYCE & ASSOCIATES LP October 21, 2026 12:31 PM - SEC Filing Form 4 OptimizeRx Corp For: Oct 01 Filed by: D'Silva Andrew J. October 2, 2026 10:00 AM - SEC Filing OptimizeRX (OPRX) PT Raised to $11 at B.Riley September 29, 2026 9:07 AM - StreetInsider OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath September 22, 2026 8:00 AM - StreetInsider OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence September 14, 2026 8:00 AM - StreetInsider OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference September 8, 2026 7:30 AM - StreetInsider OptimizeRx names former J&J data science officer as company advisor September 2, 2026 7:30 AM - StreetInsider OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor September 2, 2026 7:30 AM - StreetInsider Form 4 OptimizeRx Corp For: Aug 20 Filed by: Silvestro Stephen L August 24, 2026 4:58 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 20 Filed by: D'Silva Andrew J. August 24, 2026 4:58 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 20 Filed by: Odence-Ford Marion August 24, 2026 4:57 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 20 Filed by: Merrell Brendan W. August 24, 2026 4:57 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 21 Filed by: Merrell Brendan W. August 24, 2026 3:15 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 21 Filed by: Silvestro Stephen L August 24, 2026 3:15 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 21 Filed by: Odence-Ford Marion August 24, 2026 3:13 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 21 Filed by: D'Silva Andrew J. August 24, 2026 3:12 PM - SEC Filing Form 4 OptimizeRx Corp For: Aug 21 Filed by: Stelmakh Edward August 24, 2026 3:12 PM - SEC Filing Form S-8 OptimizeRx Corp August 20, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G OptimizeRx Corp Filed by: KENNEDY CAPITAL MANAGEMENT LLC August 14, 2026 2:07 PM - SEC Filing OptimizeRX (OPRX) PT Raised to $11 at Citizens: Positioned for Return to Growth in 2027 August 14, 2026 4:19 AM - StreetInsider Form 10-Q OptimizeRx Corp For: Jun 30 August 13, 2026 4:09 PM - SEC Filing OptimizeRX (OPRX) PT Lowered to $12 at Stifel, Buy Rating Maintained August 13, 2026 9:00 AM - StreetInsider Optimizerx Corporation (OPRX) Tops Q2 EPS by 6c August 12, 2026 4:33 PM - StreetInsider Form 8-K OptimizeRx Corp For: Aug 07 August 12, 2026 4:08 PM - SEC Filing OptimizeRx names new CFO and CAO, effective January 2027 August 12, 2026 4:07 PM - StreetInsider OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth August 12, 2026 4:05 PM - StreetInsider OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance August 12, 2026 4:01 PM - StreetInsider Form SCHEDULE 13G/A OptimizeRx Corp Filed by: BlackRock, Inc. July 29, 2026 3:21 PM - SEC Filing OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET July 29, 2026 7:30 AM - StreetInsider Full Article List